Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

This analysis evaluates the cost-effectiveness of insulin degludec (degludec) versus biosimilar insulin glargine U100 (glargine U100) in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) in Bulga...

Source: BMC Endocrine Disorders - December 3, 2019 Category: Endocrinology Authors: Monika Russel-Szymczyk, Vasil Valov, Alexandra Savova and Manoela Manova Tags: Research article Source Type: research